Cite

HARVARD Citation

    Brandhuber, B. et al. (n.d.). The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancers. European journal of cancer. pp. S144-. [Online]. 
  
Back to record